Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction less than or equal to 30% should receive an implantable cardioverter-defibrillator - Response

被引:0
|
作者
Buxton, AE
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2548 / 2548
页数:1
相关论文
共 50 条
  • [41] Who Should Receive the Subcutaneous Implanted Defibrillator? Timing Is Not Right to Replace the Transvenous Implantable Cardioverter Defibrillator
    Acha, Moshe Rav
    Milan, David
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (06): : 1246 - 1251
  • [42] Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?
    Amin, Mitesh S.
    Ellenbogen, Kenneth A.
    CURRENT OPINION IN CARDIOLOGY, 2010, 25 (01) : 23 - 28
  • [43] Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction A Window of Opportunity
    DeFilippis, Ersilia M.
    Butler, Javed
    Vaduganathan, Muthiah
    CIRCULATION-HEART FAILURE, 2017, 10 (11)
  • [45] REASSESSMENT OF CARDIAC FUNCTION AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR USE AMONG MEDICARE PATIENTS WITH LOW EJECTION FRACTION AFTER MYOCARDIAL INFARCTION
    Pokorney, Sean
    Miller, Amy Leigh
    Chen, Anita
    Thomas, Laine
    Fonarow, Gregg
    de Lemos, James
    Al-Khatib, Sana
    Peterson, Eric
    Wang, Tracy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A453 - A453
  • [46] Kidney Dysfunction and Deterioration of Ejection Fraction Pose Independent Risk Factors for Mortality in Implantable Cardioverter-Defibrillator Recipients for Primary Prevention
    Kreuz, Jens
    Horlbeck, Fritz
    Schrickel, Jan
    Linhart, Markus
    Fimmers, Rolf
    Mellert, Fritz
    Nickenig, Georg
    Schwab, Joerg Otto
    CLINICAL CARDIOLOGY, 2012, 35 (09) : 575 - 579
  • [47] Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction
    Pokorney, Sean D.
    Miller, Amy L.
    Chen, Anita Y.
    Thomas, Laine
    Fonarow, Gregg C.
    de Lemos, James A.
    Al-Khatib, Sana M.
    Velazquez, Eric J.
    Peterson, Eric D.
    Wang, Tracy Y.
    CIRCULATION, 2017, 135 (01) : 38 - +
  • [48] IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) UTILIZATION AMONG OLDER PATIENTS WITH LOW EJECTION FRACTION FOLLOWING CORONARY REVASCULARIZATION FOR MYOCARDIAL INFARCTION
    Goldstein, Sarah
    Lu, Di
    Matsouaka, Roland
    Wang, Tracy
    Rymer, Jennifer
    Pokorney, Sean
    Al-Khatib, Sana M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 379 - 379
  • [49] Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility
    Schiau, Calin
    Leucuta, Daniel-Corneliu
    Dudea, Sorin Marian
    Manole, Simona
    BIOLOGY-BASEL, 2021, 10 (11):
  • [50] A wearable cardioverter-defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction
    Sullivan, Kristen
    Van Spall, Harriette G. C.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (02) : JC5 - JC5